1. Randomized, multicenter trial to assess the efficacy, safety and tolerability of a single dose of a novel AMPA receptor antagonist BGG492 for the treatment of acute migraine attacks. (February 2014) Authors: Gomez-Mancilla, Baltazar; Brand, Ronald; Jürgens, Tim P; Göbel, Harmut; Sommer, Claudia; Straube, Andreas; Evers, Stefan; Sommer, Martin; Campos, Victor; Kalkman, Hans O; Hariry, Sam; Pezous, Nicole; Johns, Donald; Diener, Hans-Christoph Journal: Cephalalgia Issue: Volume 34:Number 2(2014) Page Start: 103 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Treatment of Sarcopenia with Bimagrumab: Results from a Phase II, Randomized, Controlled, Proof‐of‐Concept Study. Issue 9 (27th June 2017) Authors: Rooks, Daniel; Praestgaard, Jens; Hariry, Sam; Laurent, Didier; Petricoul, Olivier; Perry, Robert G.; Lach‐Trifilieff, Estelle; Roubenoff, Ronenn Journal: Journal of the American Geriatrics Society Issue: Volume 65:Issue 9(2017:Sep.) Page Start: 1988 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗